Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community C...

le Langford, Aisha T., Resnicow, Ken, Dimond, Eileen P., Denicoff, Andrea M., Germain, Diane St., McCaskill-Stevens, Worta, Enos, Rebecca A., Carrigan, Angela, Wilkinson, Kathy, Go, Ronald S.
Foilsithe 2013

ReCAP: Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community

le Dimond, Eileen P., Zon, Robin T., Weiner, Bryan J., St. Germain, Diane, Denicoff, Andrea M., Dempsey, Kandie, Carrigan, Angela C., Teal, Randall W., Good, Marjorie J., McCaskill-Stevens, Worta, Grubbs, Stephen S.
Foilsithe in J Oncol Pract (2016)

Creating a “culture of research” in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program

le Dimond, Eileen P, St. Germain, Diane, Nacpil, Lianne M, Zaren, Howard A, Swanson, Sandra M, Minnick, Christopher, Carrigan, Angela, Denicoff, Andrea M, Igo, Kathleen E, Acoba, Jared D, Gonzalez, Maria M, McCaskill-Stevens, Worta
Foilsithe in Clin Trials (2015)

Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials

le Reeve, Bryce B., Mitchell, Sandra A., Dueck, Amylou C., Basch, Ethan, Cella, David, Reilly, Carolyn Miller, Minasian, Lori M., Denicoff, Andrea M., O’Mara, Ann M., Fisch, Michael J., Chauhan, Cynthia, Aaronson, Neil K., Coens, Corneel, Bruner, Deborah Watkins
Foilsithe 2014

Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual

le St Germain, Diane, Denicoff, Andrea M., Dimond, Eileen P., Carrigan, Angela, Enos, Rebecca A., Gonzalez, Maria M., Wilkinson, Kathy, Mathiason, Michelle A., Duggan, Brenda, Einolf, Shaun, McCaskill-Stevens, Worta, Bryant, Donna M., Thompson, Michael A., Grubbs, Stephen S., Go, Ronald S.
Foilsithe 2014

Early-Phase Clinical Trials In The Community: Results From the National Cancer Institute Community Cancer Centers Program Early-Phase Working Group Baseline Assessment

le Zaren, Howard A., Nair, Suresh, Go, Ronald S., Enos, Rebecca A., Lanier, Keith S., Thompson, Michael A., Zhao, Jinxiu, Fleming, Deborah L., Leighton, John C., Gribbin, Thomas E., Bryant, Donna M., Carrigan, Angela, Corpening, Jennifer C., Csapo, Kimberly A., Dimond, Eileen P., Ellison, Christie, Gonzalez, Maria M., Harr, Jodi L., Wilkinson, Kathy, Denicoff, Andrea M.
Foilsithe 2013

Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

le Bruner, Deborah Watkins, Hanisch, Laura J, Reeve, Bryce B, Trotti, Andy M, Schrag, Deborah, Sit, Laura, Mendoza, Tito R, Minasian, Lori, O’Mara, Ann, Denicoff, Andrea M, Rowland, Julia H, Montello, Michael, Geoghegan, Cindy, Abernethy, Amy P, Clauser, Steven B, Castro, Kathleen, Mitchell, Sandra A, Burke, Laurie, Trentacosti, Ann Marie, Basch, Ethan M
Foilsithe 2011

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement

le Kim, Edward S., Bruinooge, Suanna S., Roberts, Samantha, Ison, Gwynn, Lin, Nancy U., Gore, Lia, Uldrick, Thomas S., Lichtman, Stuart M., Roach, Nancy, Beaver, Julia A., Sridhara, Rajeshwari, Hesketh, Paul J., Denicoff, Andrea M., Garrett-Mayer, Elizabeth, Rubin, Eric, Multani, Pratik, Prowell, Tatiana M., Schenkel, Caroline, Kozak, Marina, Allen, Jeff, Sigal, Ellen, Schilsky, Richard L.
Foilsithe in J Clin Oncol (2017)

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048

le Basch, Ethan, Dueck, Amylou C., Rogak, Lauren J., Mitchell, Sandra A., Minasian, Lori M., Denicoff, Andrea M., Wind, Jennifer K., Shaw, Mary C., Heon, Narre, Shi, Qian, Ginos, Brenda, Nelson, Garth D., Meyers, Jeffrey P., Chang, George J., Mamon, Harvey J., Weiser, Martin R., Kolevska, Tatjana, Reeve, Bryce B., Bruner, Deborah Watkins, Schrag, Deborah
Foilsithe in J Clin Oncol (2018)

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

le Basch, Ethan, Dueck, Amylou C., Rogak, Lauren J., Minasian, Lori M., Kelly, William Kevin, O’Mara, Ann M., Denicoff, Andrea M., Seisler, Drew, Atherton, Pamela J., Paskett, Electra, Carey, Lisa, Dickler, Maura, Heist, Rebecca S., Himelstein, Andrew, Rugo, Hope S., Sikov, William M., Socinski, Mark A., Venook, Alan P., Weckstein, Douglas J., Lake, Diana E., Biggs, David D., Freedman, Rachel A., Kuzma, Charles, Kirshner, Jeffrey J., Schrag, Deborah
Foilsithe in JAMA Oncol (2017)

The National Cancer Institute–American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and Recommendations

le Denicoff, Andrea M., McCaskill-Stevens, Worta, Grubbs, Stephen S., Bruinooge, Suanna S., Comis, Robert L., Devine, Peggy, Dilts, David M., Duff, Michelle E., Ford, Jean G., Joffe, Steven, Schapira, Lidia, Weinfurt, Kevin P., Michaels, Margo, Raghavan, Derek, Richmond, Ellen S., Zon, Robin, Albrecht, Terrance L., Bookman, Michael A., Dowlati, Afshin, Enos, Rebecca A., Fouad, Mona N., Good, Marjorie, Hicks, William J., Loehrer, Patrick J., Lyss, Alan P., Wolff, Steven N., Wujcik, Debra M., Meropol, Neal J.
Foilsithe 2013

Validity and Reliability of the U.S. National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

le Dueck, Amylou C., Mendoza, Tito R., Mitchell, Sandra A., Reeve, Bryce B., Castro, Kathleen M., Rogak, Lauren J., Atkinson, Thomas M., Bennett, Antonia V., Denicoff, Andrea M., O'Mara, Ann M., Li, Yuelin, Clauser, Steven B., Bryant, Donna M., Bearden, James D., Gillis, Theresa A., Harness, Jay K., Siegel, Robert D., Paul, Diane B., Cleeland, Charles S., Schrag, Deborah, Sloan, Jeff A., Abernethy, Amy P., Bruner, Deborah W., Minasian, Lori M., Basch, Ethan
Foilsithe in JAMA Oncol (2015)

Implementation of Timeline Reforms Speeds Initiation of National Cancer Institute–Sponsored Trials

le Abrams, Jeffrey S., Mooney, Margaret M., Zwiebel, James A., Korn, Edward L., Friedman, Steven H., Finnigan, Shanda R., Schettino, Patricia R., Denicoff, Andrea M., Kruhm, Martha G., Montello, Mike, Misra, R. Rita, Ansher, Sherry S., DiPiazza, Kate J., Souhan, Erin M., Wickerham, D. Lawrence, Giantonio, Bruce J., O’Donnell, Robert T., Sullivan, Daniel M., Soto, Nancy I., Fleming, Gini F., Prindiville, Sheila A., Petryshyn, Ray A., Hautala, Judith A., Grad, Oren, Zuckerman, Brian L., Meyer, Ralph M., Yao, James C., Baker, Laurence A., Buckner, Jan C., Hortobagyi, Gabriel N., Doroshow, James H.
Foilsithe 2013